enVVeno Medical Corp

enVVeno Medical Corporation is a medical device company developing tissue-based bioprosthetic solutions to treat venous disease, specifically targeting patients with severe chronic venous insufficiency of the deep venous system. The company develops replacement venous valves to restore unidirectional blood flow toward the heart and lungs, counteracting blood pooling and high venous pressure in the lower legs. Its primary product pipeline centers on the enVVe System, a transcatheter, non-surgical replacement valve that includes a delivery device, accessories, nose cone, and crimping mechanism. The device aims to serve patients suffering from severe chronic venous insufficiency and related leg ulcers, with implant procedures intended for vascular surgeons, interventional radiologists, and interventional cardiologists.

The company conducts its development and manufacturing activities in a 14,507-square-foot leased facility located in Irvine, California. It has thirty-three full-time employees and holds intellectual property across global jurisdictions, including nine United States patents. enVVeno Medical Corporation maintains its corporate headquarters in Irvine, California.

Summary of the business section of enVVeno Medical's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.